logo

For the Inventor, By the Inventor

Vignate, Italy

Rodolfo Testa

USPTO Granted Patents = 19

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 186(Granted Patents)


Location History:

  • Milan, IT (1984 - 1999)
  • Vignate, IT (1997 - 2006)

Company Filing History:

goldMedal16 out of 42 
 
Recordati S.a. Chemical and Pharmaceutical Company
 patents
silverMedal2 out of 9 
 
Recordati S.a.
 patents
bronzeMedal1 out of 1 
 
Recordati S.a. Chemical
 patent
4. 1 out of 2 
 
Pharmaceutical Company
 patents
where one patent can have more than one assignee

Years Active: 1984-2006

Loading Chart...
19 patents (USPTO):Explore Patents
1. 7071197 - N,N-disubstituted diazocycloalkanes (2006-07-04),
2. 6953800 - Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunction (2005-10-11),
3. 6894052 - Diarylalkylpiperazines active on the lower urinary tract (2005-05-17),
4. 6486163 - Thienopyranecarboxamide derivatives (2002-11-26),
5. 6440963 - Use of selective COX-2 inhibitors for the treatment of urinary incontinence (2002-08-27),
6. 6399614 - 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring (2002-06-04),
7. 6387909 - Thienopyranecarboxamide derivatives (2002-05-14),
8. 6306861 - Thienopyrancecarboxamide derivatives (2001-10-23),
9. 6303606 - Use of selective antagonists of the &agr;1B-adrenergic receptor for improvement of sexual dysfunction (2001-10-16),
10. 6071920 - 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 (2000-06-06),
11. 5990114 - Use of 5-HT.sub.1A receptor antagonists for the treatment of urinary (1999-11-23),
12. 5798362 - Quinazolinyl-amino derivatives having .alpha.-antagonist activity (1998-08-25),
13. 5767136 - 1,4-Dihydropyridines useful for prevention or reduction of (1998-06-16),
14. 5696139 - Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating (1997-12-09),
15. 5605896 - Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergic and (1997-02-25),

Title: Rodolfo Testa: A Creative Force in Pharmaceutical Innovations

Introduction

Rodolfo Testa, hailing from Vignate, Italy, is a notable inventor in the field of pharmaceuticals. With a remarkable portfolio of 19 patents, his contributions have significantly impacted the sector, particularly in the treatment of sexual dysfunction and innovative chemical compounds.

Latest Patents

Among his recent inventions, Rodolfo has developed N,N-disubstituted diazocycloalkanes, featuring novel chemical structures that showcase his innovative prowess. Additionally, he has presented a groundbreaking use of selective antagonists of the α1B-adrenergic receptor aimed at improving sexual dysfunction. This invention not only addresses male and female sexual dysfunction but also focuses on pharmaceutical compositions that can assist those affected while minimizing adverse effects, such as acute hypotension.

Career Highlights

Rodolfo's career includes significant tenures at Recordati S.p.A., a reputable chemical and pharmaceutical company. His work there has enabled him to play a critical role in the development of new therapeutic approaches, showcasing his dedication to enhancing patient outcomes through innovation.

Collaborations

Throughout his professional journey, Rodolfo has collaborated with esteemed colleagues, including Amedeo Leonardi and Gianni Motta. These partnerships have further enriched his research and inventions, leading to more robust solutions in the pharmaceutical landscape.

Conclusion

Rodolfo Testa stands as a testament to the power of innovation in the pharmaceutical industry. His numerous patents and contributions underscore the significance of creativity and collaboration in advancing healthcare solutions. As he continues to push the boundaries of scientific research, his work serves as an inspiration for future inventors in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…